Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice

Regulatory Toxicology and Pharmacology

Volumn 76, Issue , 2016, Pages 234-261

  Arts, Josje H E ^a   Irfan, Muhammad Adeel ^b   Keene, Athena M ^c   Kreiling, Reinhard ^d   Lyon, Delina ^e   Maier, Monika ^f   Michel, Karin ^g   Neubauer, Nicole ^b   Petry, Thomas ^h   Sauer, Ursula G ⁱ   Warheit, David ^j   Wiench, Karin ^b   Wohlleben, Wendel ^b   Landsiedel, Robert ^b  

^a AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

^b BASF SE   (Germany)

^c AFTON CHEMICAL CORPORATION   (United States)

^d CLARIANT PRODUKTE DEUTSCHLAND GMBH   (Germany)

^e SHELL OIL COMPANY   (United States)

^f Evonik Resource Efficiency GmbH   (Germany)

^g HENKEL KGAA   (Germany)

^h ToxMinds Consultants   (Belgium)

ⁱ Scientific Consultancy Animal Welfare   (Germany)

^j CHEMOURS COMPANY   (United States)

more..

Author keywords

Amorphous silica nanomaterials; Apical toxic effects; Biopersistence and biodistribution; Carbonaceous nanomaterials; Cellular effects; Grouping; Intrinsic material and system dependent properties; Metal oxide and metal sulphate nanomaterials; Organic pigments; Read across

Indexed keywords

CARBON NANOTUBE; COPPER OXIDE NANOPARTICLE; GRAPHENE; MAGNETITE NANOPARTICLE; METAL NANOPARTICLE; MULTI WALLED NANOTUBE; NANOMATERIAL; SILICA NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ZINC OXIDE NANOPARTICLE;

ARTICLE; CYTOTOXICITY; DATA ANALYSIS; DISPERSION; DISSOLUTION; GENOTOXICITY; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHALATION; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SOLUBILITY; ANIMAL; BENCHMARKING; CELL CULTURE; CHEMISTRY; CLASSIFICATION; DECISION SUPPORT SYSTEM; MUTAGEN TESTING; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PROCEDURES; RISK ASSESSMENT; STANDARDS; SURFACE PROPERTY; TOXICITY TESTING; WORKFLOW;

ANIMALS; BENCHMARKING; CELLS, CULTURED; DECISION SUPPORT TECHNIQUES; HUMANS; METAL NANOPARTICLES; MUTAGENICITY TESTS; NANOTUBES, CARBON; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PARTICLE SIZE; RISK ASSESSMENT; SOLUBILITY; SURFACE PROPERTIES; TOXICITY TESTS; WORKFLOW;

EID: 84954304874     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.11.020     Document Type: Article

References (127)

1. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29:730-741.
2. Aschberger K., Johnston H.J., Stone V., Aitken R.J., Tran C.L., Hankin S.M., Peters S.A., Christensen F.M. Review of fullerene toxicity and exposure-appraisal of a human health risk assessment, based on open literature. Regul. Toxicol. Pharmacol. 2010, 58:455-473.
3. Arts J.H., Muijser H., Duistermaat E., Junker K., Kuper C.F. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem. Toxicol. 2007, 45:1856-1867.
4. Arts J.H., Hadi M., Keene A.M., Kreiling R., Lyon D., Maier M., Michel K., Petry T., Sauer U.G., Warheit D., Wiench K., Landsiedel R. A critical appraisal of existing concepts for the grouping of nanomaterials. Regul. Toxicol. Pharmacol. 2014, 70:492-506.
5. Arts J.H., Hadi M., Irfan M.A., Keene A.M., Kreiling R., Lyon D., Maier M., Michel K., Petry T., Sauer U.G., Warheit D., Wiench K., Wohlleben W., Landsiedel R. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul. Toxicol. Pharmacol. 2015, 71(Suppl. 2):S1-S27.
6. Baierl T., Seidel A. In vitro effects of fullerene C60 and fullerene black on immuno-functions of macrophages. Fullerene Sci. Technol. 1996, 4:1073-1078.
7. Baker G.L., Gupta A., Clark M.L., Valenzuela B.R., Staska L.M., Harbo S.J., Pierce J.T., Dill J.A. Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol. Sci. 2008, 101(1):122-131.
8. BAuA German Federal Institute for Occupational Safety and Health. Announcement regarding hazardous substances. Manufactured nanomaterials. BekGS 527. BMBl 2013, 25:498-511. see. http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/Bekanntmachung-527.html.
9. BAuA German Federal Institute for Occupational Safety and Health. Technical rule regarding hazardous substances. Register of carcinogenic, mutagenic or toxic to reproduction substances. GMBl 2014, 2013:510-522. see. http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/TRGS-905.html.
10. Bellmann B. 14-day Nose-only Inhalation Toxicity Study of Z-COTE HP1 in Wistar WU Rats. 02 G 09 005 (Draft Report) 2011, (Fraunhofer ITEM, Germany. Study owner: Cefic, Belgium).
11. Bermudez E., Mangum J.B., Wong B.A., Asgharian B., Hext P.M., Warheit D.B., Everitt J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 2004, 77:347-357.
12. Boland S., Hussain S., Baeza-Squiban A. Carbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicity. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2014, 6:641-652.
13. Bräu M., Ma-Hock L., Hesse C., Nicoleau L., Strauss V., Treumann S., Wiench K., Landsiedel R., Wohlleben W. Nanostructured calcium silicate hydrate seeds accelerate concrete hardening: a combined assessment of benefits and risks. Arch. Toxicol. 2012, 86:1077-1087.
14. Bruinink A., Wang J., Wick P. Effect of particle agglomeration in nanotoxicology. Arch. Toxicol. 2015, 89:659-675.
15. Cefic LRI European Chemical Industry Council - Long-range Research Initiative N5-FRAU: Histopathology of Rats Exposed to Barium Sulfate Nanoparticles by Life-time Inhalation Exposure - Effects and Biokinetics 2015, Available at:. http://cefic-lri.org/projects/n5-frau-histopathology-of-rats-exposed-to-barium-sulfate-nanoparticles-by-life-time-inhalation-exposure-effects-and-biokinetics/.
16. Chen K.L., Elimelech M. Relating colloidal stability of fullerene (C60) nanoparticles to nanoparticle charge and electrokinetic properties. Environ. Sci. Technol. 2009, 43(19):7270-7276.
17. Creutzenberg O. Draft 5-day Nose-only Inhalation Toxicity Study of Z-COTE® HP1 in Wistar WU Rats (DRF Study) 02 N 09 515 (Draft Report) 2009, (Fraunhofer ITEM, Germany. Study owner: Cefic, Belgium).
18. Creutzenberg O. 3-month Nose-only Inhalation Toxicity Study of Z-COTE HP1 in Wister WU Rats. 02 G 10 024 2011, (Fraunhofer ITEM, Germany. Study owner: Cefic, Belgium).
19. th Annual Meeting of the Society of Toxicology (SOT), 23-27 Mar 2014, Phoenix, AZ, USA 2014.
20. DeLorme M.P., Muro Y., Arai T., Banas D.A., Frame S.R., Reed K.L., Warheit D.B. Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats. Toxicol. Sci. 2012, 128:449-460.
21. th Annual Meeting of the Society of Toxicology (SOT), 22-26 Mar 2015, San Diego, CA, USA 2015.
22. ECETOC TR 122. Poorly Soluble Particles December 2013, Lung Overload.
23. ECHA European Chemicals Agency Guidance on Information Requirements and Chemical Safety Assessment 2008, (Chapter R.6), QSARs and Grouping of Chemicals, 134 pp. http://echa.europa.eu/documents/10162/13632/information_requirements_r6_en.pdf.
24. ECHA European Chemicals Agency Assessment of Read-across in REACH 2012, 58 pp.
25. ECHA European Chemicals Agency Background Paper. An introduction to the assessment of read-across. Experts Workshop on Read-across Assessment with the Active Support of Cefic LRI. 2-3 Oct 2012 2012, 8 pp. http://echa.europa.eu/documents/10162/5649897/ws_raa_20121003_background_paper_an_introduction_to_the_assessment_of_read-across_in_echa_en.pdf.
26. ECHA European Chemicals Agency. Grouping of Substances and Read-across Approach 2013, Part I. Introductory note. ECHA-13-R-02-EN, Apr 2013, 11 pp.
27. ECHA European Chemicals Agency. Human health and environmental exposure assessment and risk characterization of nanomaterials. Best practice for REACH registrants. Third GAARN Meeting - Helsinki, 30 Sep 2013. ECHA-14-R-10-EN 2014, 12 pp.
28. Elder A., Gelein R., Finkelstein J.N., Driscoll K.E., Harkema J., Oberdörster G. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol. Sci. 2005, 88:614-629.
29. EP and Council of the EU Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency, Amending Directive 1999/45/EC and Repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as Well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396/1, 30 Dec 2006 2006.
30. EPA Environmental Protection Agency. Proposed Rule - Chemical Substances When Manufactured or Processed as Nanoscale Materials; TSCA Reporting and Recordkeeping Requirements. FRL: 9920-90. Docket No. EPA-HQ-OPPT-2010-0572 2015, Prepublication Copy Notice, 20 Mar 2015.
31. EU Commission Commission Recommendation on the Definition of Nanomaterial 2011, OJ L 275/38, 18 Oct 2011.
32. Fraunhofer I.K.T.S. Physico-chemical Characterization of SiO2 NM-200 2012, Final Report. 30 Oct. 2012, Dresden.
33. ® and a Microscaled ZnO Sample in Various Simulated Lung Fluids 2015, Final Report No. 09N15/HKOC. 14 January 2015.
34. Froggett S.J., Clancy S.F., Boverhof D.R., Canady R.A. A review and perspective of existing research on the release of nanomaterials from solid nanocomposites. Part. Fibre Toxicol. 2014, 11:17.
35. Gebel T., Landsiedel R. Proceedings of safety research: long-term effects of biodurable dusts. Hazardous substances - air pollution prevention. Inhalte der Sicherheitsforschung: Langzeitwirkung biobeständiger Stäube. Gefahrst. Reinhalt. Luft 2013, 73(10):414-415.
36. Godwin H., Nameth C., Avery D., Bergeson L.L., Bernard D., Beryt E., Boyes W., Brown S., Clippinger A.J., Cohen Y., Doa M., Hendren C.O., Holden P., Houck K., Kane A.B., Klaessig F., Kodas T., Landsiedel R., Lynch I., Malloy T., Miller M.B., Muller J., Oberdörster G., Petersen E.J., Pleus R.C., Sayre P., Stone V., Sullivan K.M., Tentschert J., Wallis P., Nel A.E. Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 2015, 9(4):3409-3417.
37. th Annual Meeting of the Society of Toxicology (SOT), 22-26 Mar 2015, San Diego, CA, USA 2015.
38. Guldberg M., Christensen V.R., Krois W., Sebastian K. Method for determining in vitro dissolution rates of man-made vitreous fibres. Glass Sci. Technol. 1995, 68:181-187.
39. Hahn D., Wiemann M., Haase A., Ossig R., Alessandrini F., M-Hock L., Landsiedel R., Nern M., Vennemann A., Driessen M.D., Luch A., Dopp E., Schnekenburger J. Toxicological effects of metal oxide nanomaterials. Safety of Nanomaterials along Their Lifecycle: Release, Exposure, Human Hazards 2014, 191-211. (Chapter 8), CRC Press, Boca Raton, USA. W. Wohlleben, T.A.J. Kuhlbusch, C.M. Lehr, J. Schnekenburger (Eds.).
40. Henderson R.F., Driscoll K.E., Harkema J.R., Lindenschmidt R.C., Chang I.Y., Maples K.R., Barr E.B. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam. Appl. Toxicol. 1995, 24:183-197.
41. Hendren C.O., Lowry G.V., Unrine J.M., Wiesner M.R. A functional assay-based strategy for nanomaterial risk forecasting. Sci. Total Env. 2015, 536:1029-1037.
42. Hsieh S.F., Bello D., Schmidt D.F., Pal A.K., Stella A., Isaacs J.A., Rogers E.J. Mapping the biological oxidative damage of engineered nanomaterials. Small 2013, 9(9-10):1853-1865.
43. ISO Technical Specification. Nanotechnologies - Occupational Risk Management Applied to Engineered Nanomaterials - Part 2: Use of the Control Banding Approach. ISO/TS 12901-2 2014, 2014-01-15. first ed.
44. ISO Technical Specification. Nanotechnologies - Vocabulary. Part 2: Nano-objects. ISO/TS 80004-2 2015, 2015-06-01. first ed.
45. Izak-Nau E., Voetz M. As-produced: intrinsic physico-chemical properties and appropriate characterization tools. Safety of Nanomaterials along Their Lifecycle: Release, Exposure, and Human Hazards 2014, 3-23. CRC Press Boca Raton, London, New York. W. Wohlleben, T.A.J. Kuhlbusch, J. Schnekenburger, C.-M. Lehr (Eds.).
46. Jacobsen N.R., Pojana G., White P., Moller P., Cohn C.A., Korsholm K.S., Vogel U., Marcomini A., Loft S., Wallin H. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Muta™ mouse lung epithelial cells. Environ. Mol. Mutagen 2008, 49(6):476-487.
47. Karlsson H.L., Cronholm P., Gustafsson J., Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
48. Karlsson H.L., Gliga A.R., Calléja F.M., Gonçalves C.S., Wallinder I.O., Vrieling H., Fadeel B., Hendriks G. Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines. Part. Fibre Toxicol. 2014, 11:41.
49. Keller J., Wohlleben W., Ma-Hock L., Groeters S., Küttler K., Strauss V., Wiench K.E., Herden C., Oberdörster G., van Ravenzwaay B., Landsiedel R. Time-course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch. Toxicol. 2014, 88:2033-2059.
50. Keller J. Biokinetics and Inhalation Toxicity of Cerium Dioxide and Barium Sulfate Nanoparticles after 1, 4, 13 and 52 Weeks of Exposure 2015, Doctoral thesis, faculty of veterinary medicine, Justus Liebig University of Gießen, Germany.
51. Konduru N., Keller J., Ma-Hock L., Gröters S., Landsiedel R., Donaghey T.C., Brain J.D., Wohlleben W., Molina R.M. Biokinetics and effects of barium sulfate nanoparticles. Part. Fibre Toxicol. 2014, 11:55.
52. Kroll A., Dierker C., Rommel C., Hahn D., Wohlleben W., Schulze-Isfort C., Göbbert C., Voetz M., Hardinghaus F., Schnekenburger J. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part. Fibre Toxicol. 2011, 8:9.
53. Kuempel E.D., Castranova V., Geraci C.L., Schulte P.A. Development of risk-based nanomaterial groups for occupational exposure control. J. Nanopart. Res. 2012, 14:1029-1043.
54. NanoCare - Health Related Effects of Nanoparticles 2009, Dechema e.V., Frankfurt, Final scientific report. T.A.J. Kuhlbusch, H.F. Krug, K. Nau (Eds.).
55. Landsiedel R., Ma-Hock L., van Ravenzwaay B., Schulz M., Wiench K., Champ S., Schulte S., Wohlleben W., Oesch F. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations. Nanotoxicology 2010, 4:364-381.
56. Landsiedel R., Ma-Hock L., Hofmann T., Wiemann M., Strauss V., Treumann S., Wohlleben W., Groters S., Wiench K., van Ravenzwaay B. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part. Fibre Toxicol. 2014, 11:16.
57. Landsiedel R., Schnekenburger J., Alessandrini F., Buesen R., Haase A., Luch A., Ma-Hock L., Wiemann M. nanoGEM Final Project Report (Gemeinsamer Abschlussbericht NanoGEM). Work Package 4 (AP4): Nanoparticle Toxicology: Material Properties and Effects 2014, (Chapter 6), (project report in German).
58. Landsiedel R., Sauer U.G., Ma-Hock L., Schnekenburger J., Wiemann M. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays with in vivo inhalation or instillation studies. Nanomedicine 2014, 9:2557-2585.
59. Landsiedel Robert. Concern-driven integrated approaches for the grouping, testing and assessment of nanomaterials. Environ. Pollut. 2015, 10.1016/j.envpol.2015.10.060.
60. Luoto K., Holopainen M., Karppinen K., Perander M., Savolainen K. Dissolution of man-made vitreous fibers in rat alveolar macrophage culture and Gamble's saline solution: influence of different media and chemical composition of the fibers. Environ. Health Perspect. 1994, 102(Suppl. 5):103-107.
61. Lynch I., Weiss C., Valsami-Jones E. A strategy for grouping of NMs based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano Today 2014, 9:266-270.
62. Ma-Hock L., Gamer A.O., Landsiedel R., Leibold E., Frechen T., Sens B., Linsenbuehler M., van Ravenzwaay B. Generation and characterization of test atmospheres with nanomaterials. Inhal. Toxicol. 2007, 19:833-848.
63. Ma-Hock L., Burkhardt S., Strauss V., Gamer A.O., Wiench K., van Ravenzwaay B., Landsiedel R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 2009, 21:102-118.
64. Ma-Hock L., Treumann S., Strauss V., Brill S., Luizi F., Mertler M., Wiench K., Gamer A.O., van Ravenzwaay B., Landsiedel R. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol. Sci. 2009, 112:468-481.
65. Ma-Hock L., Strauss V., Treumann S., Kuttler K., Wohlleben W., Hofmann T., Groters S., Wiench K., van Ravenzwaay B., Landsiedel R. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part. Fibre Toxicol. 2013, 10:23.
66. Marcus Y., Smith A.L., Korobov M.V., Mirakyan A.L., Avramenko N.V., Stukalin E.B. Solubility of C60 fullerene. J. Phys. Chem. B 2001, 105:2499-2506.
67. Marucco A., Catalano F., Fenoglio I., Turci F., Martra G., Fubini B. Possible chemical source of discrepancy between in vitro and in vivo tests in nanotoxicology caused by strong adsorption of buffer components. Chem. Res. Toxicol. 2015, Epub ahead of print 7 Jan 2015 Jan 7.
68. 2 nanomaterials. Mut. Res. 2015, 794:57-74.
69. Mitrano D.M., Motellier S., Clavaguera S., Nowack B. Review of nanomaterial aging and transformations through the life cycle of nano-enhanced products. Environ. Int. 2015, 77:132-147.
70. Moreno-Horn M., Gebel T. Granular biodurable nanomaterials: no convincing evidence for systemic toxicity. Crit. Rev. Toxicol. 2014, 44:849-875.
71. Morimoto Y., Hirohashi M., Ogami A., Oyabu T., Myojo T., Nishi K., Kadoya C., Todoroki M., Yamamoto M., Murakami M., et al. Inflammogenic effect of well-characterized fullerene in inhalation and intratracheal instillation studies. Part. Fibre Toxicol. 2010, 7:1-18.
72. Muhle H., Kittel B., Ernst H., Mohr U., Mermelstein R. Neoplastic lung lesions in rat after chronic exposure to crystalline silica. Scand. J. Work Environ. Health 1995, 21(Suppl. 2):27-29.
73. NANOGENOTOX Deliverable 4.3: Crystallite Size, Mineralogical and Chemical Purity of NANOGENOTOX Nanomaterials, Key Intrinsic Physicochemical Characteristics of NANOGENOTOX Nanomaterials 2012, final report, deliverable leader: K.A. Jensen, NRCWE, Denmark, NANOGENOTOX, October 2012, available at:. http://www.nanogenotox.eu.
74. NANOGENOTOX Deliverable 5: In Vitro Testing Strategy for Nanomaterials Including Database 2013, final report, Deliverable leader: H. Norppa, FIOSH, Finland, NANOGENOTOX, March 2013, available at:. http://www.nanogenotox.eu.
75. NANOGENOTOX Deliverable 6: Characterisation of Manufactured Nanomaterials for Their Clastogenic/aneugenic Effects or DNA Damage Potentials and Correlation Analysis 2013, final report, Deliverable leader: V. Fessard, ANSES, France, NANOGENOTOX, March 2013, available at:. http://www.nanogenotox.eu.
76. NANO SUPPORT Project Scientific Technical Support on Assessment of Nanomaterials in REACH Registration Dossiers and Adequacy of Available Information. AA N°07.0307/2010/581080/AA/D3 between DG Environment (DG ENV) and the Joint Research Centre (JRC). Final Report on Analysis and Assessment (Task I, Step 3&4&5) and Options for Adapting REACH (Task II, Step 1), F.M. Christensen (JRC Technical Responsible) Nanosafety & Regulatory Methods Competence Group I.04 Nanobiosciences Unit JRC-IHCP, Addressed to DG ENV D.3 Attn.: H. Laursen (ENV D.3 Technical Responsible), Ref. Ares(2012)314828, 16 Mar 2012 2012, http://ec.europa.eu/environment/chemicals/nanotech/pdf/jrc_report.pdf.
77. st century: use of a predictive toxicological approach and high-throughput screening. Acc. Chem. Res. 2013, 46:607-621.
78. Nel A.E., Parak W.J., Chan W.C., Xia T., Hersam M.C., Brinker C.J., Zink J.I., Pinkerton K.E., Baer D.R., Weiss P.S. Where are we heading in nanotechnology environmental health and safety and materials characterization?. ACS Nano 2015, 9:5627-5630.
79. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 2004, 112:1058-1062.
80. Oberdörster G., Elder A., Rinderknecht A. Nanoparticles and the brain: cause for concern?. J. Nanosci. Nanotechnol. 2009, 9:4996-5007.
81. OECD OECD Guideline for the Testing of Chemicals No. 412. Subacute Inhalation Toxicity: 28-day Study, OECD, Paris, France, 7 Sep 2009 2009.
82. OECD, 2014. Guidance on grouping of chemicals, second ed. Series on Testing and Assessment No. 194. ENV/JM/MONO(2014)4, OECD, Paris, France, 14 Apr 2014.
83. OECD Series on the Safety of Manufactured Nanomaterials. No. 44. Dossier on Cerium Oxide. ENV/JM/MONO(2015)8, 29 May 2015 2015.
84. OECD Series on the Safety of Manufactured Nanomaterials. No. 49. Dossier on Multiwalled Carbon Nanotubes (MWCNT). Parts 1-3. ENV/JM/MONO(2015)12/PART1-3, 4 June 2015 2015.
85. OECD Series on the Safety of Manufactured Nanomaterials. No. 51. Dossier on Silicon Dioxide (NM 200) Part 1, ENV/JM/MONO(2015)14/PART1, 2 June 2015 2015.
86. OECD Series on the Safety of Manufactured Nanomaterials. No. 51. Dossier on Silicon Dioxide (NM 203) Part 4, ENV/JM/MONO(2015)14/PART1, 2 June 2015 2015.
87. OECD Series on the Safety of Manufactured Nanomaterials. No. 45. Dossier on Cerium Oxide - Annex 2. ENV/JM/MONO(2015)8/ANN2, 3 June 2015 2015.
88. OECD Work Plan for the Test Guidelines Programme. 1 July 2015 2015, Available at:. http://www.oecd.org/env/ehs/testing/TGP%20work%20plan_declassification_July%202015.pdf.
89. Oomen A.G., Bos P.M.J., Fernandes T.F., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., van der Kammer F., Kühnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment - report of the NanoSafety Cluster Working Group 10. Nanotoxicology 2014, 8:334-348.
90. Oomen A.G., Bleeker E., Bos P.M.J., van Broekhuizen F., Gottardo S., Groenewold M., Hristozov D., Hund-Rinke K., Irfan M.-A., Marcomini A., Peijnenburg W.J.G.M., Rasmussen K., Sánchez Jiménez A., Scott-Fordsmand J.J., van Tongeren M., Wiench K., Wohlleben W., Landsiedel R. Grouping and read-across approaches for risk assessment of nanomaterials. Int. J. Environ. Res. Public Health 2015, 12:13415-13434.
91. Pal A.K., Bello D., Cohen J., Demokritou P. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials. Nanotoxicology 2015, 12:1-15.
92. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 2010, 113:226-242.
93. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A., Seaton A., Stone V., Brown S., Macnee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotech. 2008, 3:423-428.
94. Poland C.A., Duffin R., Donaldson K. High aspect nanoparticles and the fibre pathogenicity paradigm. Nanotoxicity: from In Vivo and In Vitro Models to Health Risks 2009, Wiley-VCH Verlag GmbH, Weinheim, Germany, (Chapter 4). S.C. Sahu, D.A. Casciano (Eds.).
95. Pothmann D., Simar S., Schuler D., Dony E., Gaering S., Le Net J.L., Okazaki Y., Chabagno J.M., Bessibes C., Beausoleil J., Nesslany F., Régnier J.F. Lung inflammation and lack of genotoxicity in the comet and micronucleus assays of industrial multiwalled carbon nanotubes Graphistrength(©) C100 after a 90-day nose-only inhalation exposure of rats. Part Fibre Toxicol. 2015, 12:21.
96. Poulsen S.S., Saber A.T., Williams A., Andersen O., Købler C., Atluri R., Pozzebon M.E., Mucelli S.P., Simion M., Rickerby D., Mortensen A., Jackson P., Kyjovska Z.O., Mølhave K., Jacobsen N.R., Jensen K.A., Yauk C.L., Wallin H., Halappanavar S., Vogel U. MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs. Toxicol. Appl. Pharmacol. 2015, 284:16-32.
97. Rasmussen K., Mast J., De Temmerman P.-J., Verleysen E., Waegeneers N., van Steen F., Pizzolon J.C., De Temmerman L., van Doren E., Alstrup Jensen K., Birkedal R., Levin M., Hjortkjær Nielsen S., Kalevi Koponen I., Clausen P.A., Kofoed-Sørensen V., Kembouche Y., Thieriet N., Spalla O., Guiot C., Rousset D., Witschger O., Bau S., Bianchi B., Motzkus C., Shivachev B., Dimowa L., Nikolova R., Nihtianova D., Tarassov M., Petrov O., Bakardjieva S., Gilliland D., Pianella F., Ceccone G., Spampinato V., Cotogno G., Gibson N., Gaillard C., Mech A. Titanium Dioxide, NM-100, NM-101, NM- 102, NM-103, NM-104, NM-105: Characterisation and Physico-chemical Properties. JRC Repository: NM-series of Representative Manufactured Nanomaterials 2014, JRC Science and Policy Report. EUR 26637 EN.
98. Reuzel P.G., Bruijntjes J.P., Feron V.J., Woutersen R.A. Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food Chem. Toxicol. 1991, 29:341-354.
99. Ruenraroengsak P., Tetley T.D. Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells. Part. Fibre Toxicol. 2015, 12:19.
100. Sauer U.G., Vogel S., Aumann A., Hess A., Kolle S.N., Ma-Hock L., Wohlleben W., Dammann M., Strauss V., Treumann S., Gröters S., Wiench K., van Ravenzwaay B., Landsiedel R. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. Toxicol. Appl. Pharmacol. 2014, 276:1-20.
101. Sauer U.G., Aumann A., Ma-Hock L., Landsiedel R., Wohlleben W. Influence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro. Toxicol. In Vitro 2014, 29:182-186.
102. SCCS Scientific Committee on Consumer Safety Opinion on Carbon Black (Nano-form), 12 Dec 2013, SCCS/1515/13, Revision of 27 Mar 2014 2014.
103. SCGOS (Swedish Criteria Group for Occupational Standards) Scientific basis for Swedish occupational standards XXXIII. N-Methyl-2-pyrrolidone, Cryst. silica, quartz, epichlorohydrin. Nr. 2014, 48 (3) 2014, ISBM 978-91-85971-52-7.
104. Schaefer J., Schulze C., Marxer E.E., Schaefer U.F., Wohlleben W., Bakowsky U., Lehr C.M. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. ACS Nano 2012, 6:4603-4614.
105. Schrage A., Hempel K., Schulz M., Kolle S.N., van Ravenzwaay B., Landsiedel R. Refinement and reduction of acute oral toxicity testing: a critical review of the use of cytotoxicity data. Altern. Lab. Anim. 2011, 39:273-295.
106. Schuler D., Reed K.L., DeLorme M.P., Okazaki Y., Muro Y., Chevalier H.J., Warheit D.B. Thirteen-week inhalation toxicity study with a multiwall carbon nanotube test material in Wistar rats. Poster No. 464 at the 52th Annual Meeting of the Society of Toxicology (SOT), 10-14 Mar 2013, San Antonio, TX, USA 2013.
107. Sellers K., Deleebeeck N.M.E., Messiaen M., Jackson M., Bleeker E.A.J., Sijm D.T.H.M., van Broekhuizen F.A. Grouping Nanomaterials. A Strategy towards Grouping and Read-across 2015, RIVM Report 2015-0061, RIVAM - National Institute for Public Health and the Environment, NL, 227 pp.
108. Shinohara N., Gamo M., Nakanishi J. Fullerene C60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. Toxicol. Sci. 2011, 123:576-589.
109. Singh C., Friedrichs S., Levin M., Birkedal R., Jensen K.A., Pojana G., Wohlleben W., Schulte S., Wiench K., Turney T., Koulaeva O., Marshall D., Hund-Rinke K., Koerdel W., van Doren E., De Temmerman P.J., Abi Daoud F.M., Mast J., Gibson N., Koeber R., Linsinger T., Klein C.L. NM Series of Representative Manufactured Nanomaterials, Zinc Oxide NM-110, NM-111, NM-112, NM-113. Characterisation and Test Item Preparation 2011, EUR 25066 EN, ISBN 978-92-79-22215-3.
110. Singh C., Friedrichs S., Ceccone G., Gibson P., Jensen K.A., Levin M., Goenaga Infante H., Carlander D., Rasmussen K. Cerium Dioxide, NM-211, NM-212, NM-213. Characterisation and Test Item Preparation 2014, EUR 26649.
111. Smulders S., Luyts K., Brabants G., Golanski L., Martens J., Vanoirbeek J., Hoet P.H. Toxicity of nanoparticles embedded in paints compared to pristine nanoparticles, in vitro study. Toxicol. Lett. 2015, 232:333-339.
112. Son J., Vavra J., Li Y., Seymour M., Forbes V. Interactions between suspension characteristics and physicochemical properties of silver and copper oxide nanoparticles: a case study for optimizing nanoparticle stock suspensions using a central composite design. Chemosphere 2015, 124:136-142.
113. Stefaniak A.B., Hackley V.A., Roebben G., Ehara K., Hankin S., Postek M.T., Lynch I., Fu W.E., Linsinger T.P., Thünemann A.F. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 2013, 7:1325-1337.
114. Tantra R., Boyd R., Cackett A., Fry T., Gohil D., Goldberg S., Lee J., Minelli C., Peck R., Quincey P., Smith S., Snowden J., Spencer S., Tompkins J., Wang J., Yang L. Final Report on the Physico-chemical Characterisation of PROSPEcT Engineered Nanomaterials 2012, NPL (National Physical Library) Report AS 68, Middlesex, UK, 68 pp. 1754-2928.
115. Totsuka Y., Higuchi T., Imai T., Nishikawa A., Nohmi T., Kato T., Masuda S., Kinae N., Hiyoshi K., Ogo S., Kawanishi M., Yagi T., Ichinose T., Fukumori N., Watanabe M., Sugimura T., Wakabayashi K. Genotoxicity of nano/microparticles in in vitro micronuclei, in vivo comet and mutation assay systems. Part. Fibre Toxicol. 2009, 6:23.
116. UBA Umweltbundesamt - Federal Environmental Agency. Carcinogenicity and Mutagenicity of Nanoparticles - Assessment of Current Knowledge as Basis for Regulation 2014, Project No. (FKZ) 3709 61 220 Report No. (UBA-FB) 001725/E. Submitted by: Schröder, K., Pohlenz-Michel, C., Simetska, N., Voss, J.U., Escher, S., Mangelsdorf, I., Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover. Texte 50/2014, 163 pp.
117. Uboldi C., Giudetti G., Broggi F., Gilliland D., Ponti J., Rossi F. Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. Mutat. Res. 2012, 745(1-2):11-20.
118. United Nations Globally Harmonised System of Classification and Labelling of Chemicals 2011, United Nations, New York and Geneva, ST/SG/AC.10/30/Rev. 4, 561 pp. fourth revised edition.
119. 2 and quartz. Toxicol. Lett. 2009, 186:152-159.
120. Walser T., Studer C. Sameness: the regulatory crux with nanomaterial identity and grouping schemes for hazard assessment. Regul. Toxicol. Pharmacol. 2015, 72:569-571.
121. WHO Man-made Mineral Fibres. Environmental Health Criteria 77 1988, World Health Organization, Geneva, Switzerland.
122. WHO Air Quality Guidelines for Europe 2005, World Health Organization, see. http://www.euro.who.int/__data/assets/pdf_file/0005/74732/E71922.pdf, second ed.
123. th Annual Meeting of the Society of Toxicology (SOT), 22-26 Mar 2015, San Diego, CA, USA 2015.
124. Wiemann M., Vennemann A., Wiench K., Sauer U.G., Ma-Hock L., Landsiedel R. An Alveolar Macrophage Assay for Predicting the Short-term Inhalation Toxicity of Nanomaterials 2015, (submitted for publication).
125. Wohlleben W., Ma-Hock L., Boyko V., Cox G., Egenolf H., Freiberger H., Hinrichsen B., Hirth S., Landsiedel R. Nanospecific guidance in REACH: a comparative physical chemical characterization of 15 materials with methodical correlations. J. Ceram. Sci. Technol. 2013, 4:93-104.
126. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
127. Zhang H., Ji Z., Xia T., Meng H., Low-Kam C., Liu R., Pokhrel S., Lin S., Wang X., Liao Y.-P., Wang M., Li L., Rallo R., Damoiseaux R., Telesca D., Mädler L., Cohen Y., Zink J.I., Nel A.E. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6(5):4349-4368.